vs
Side-by-side financial comparison of Ceribell, Inc. (CBLL) and Community West Bancshares (CWBC). Click either name above to swap in a different company.
Community West Bancshares is the larger business by last-quarter revenue ($38.3M vs $24.8M, roughly 1.5× Ceribell, Inc.). Community West Bancshares produced more free cash flow last quarter ($43.6M vs $-11.0M).
Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.
Community West BancsharesCWBCEarnings & Financial Report
Community West Bancshares is a registered bank holding company headquartered in California. It wholly owns Community West Bank under the Bank Holding Company Act.
CBLL vs CWBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $24.8M | $38.3M |
| Net Profit | $-13.5M | — |
| Gross Margin | 87.3% | — |
| Operating Margin | -58.9% | 40.0% |
| Net Margin | -54.6% | — |
| Revenue YoY | — | 11.6% |
| Net Profit YoY | — | — |
| EPS (diluted) | $-0.35 | $0.58 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $24.8M | $38.3M | ||
| Q3 25 | $22.6M | $37.9M | ||
| Q2 25 | $21.2M | $35.7M | ||
| Q1 25 | $20.5M | $34.8M | ||
| Q4 24 | — | $34.3M | ||
| Q3 24 | $17.2M | $31.3M | ||
| Q2 24 | — | $30.5M | ||
| Q1 24 | — | $20.7M |
| Q4 25 | $-13.5M | — | ||
| Q3 25 | $-13.5M | $10.9M | ||
| Q2 25 | $-13.6M | $7.8M | ||
| Q1 25 | $-12.8M | $8.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-10.4M | $3.4M | ||
| Q2 24 | — | $-6.3M | ||
| Q1 24 | — | $3.7M |
| Q4 25 | 87.3% | — | ||
| Q3 25 | 88.3% | — | ||
| Q2 25 | 88.1% | — | ||
| Q1 25 | 87.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 87.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -58.9% | 40.0% | ||
| Q3 25 | -64.8% | 39.8% | ||
| Q2 25 | -70.5% | 30.2% | ||
| Q1 25 | -69.3% | 32.7% | ||
| Q4 24 | — | 31.0% | ||
| Q3 24 | -57.8% | 13.3% | ||
| Q2 24 | — | -25.9% | ||
| Q1 24 | — | 23.2% |
| Q4 25 | -54.6% | — | ||
| Q3 25 | -59.6% | 28.7% | ||
| Q2 25 | -64.4% | 22.0% | ||
| Q1 25 | -62.4% | 23.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | -60.6% | 10.8% | ||
| Q2 24 | — | -20.7% | ||
| Q1 24 | — | 17.8% |
| Q4 25 | $-0.35 | $0.58 | ||
| Q3 25 | $-0.37 | $0.57 | ||
| Q2 25 | $-0.38 | $0.41 | ||
| Q1 25 | $-0.36 | $0.44 | ||
| Q4 24 | — | $0.29 | ||
| Q3 24 | $-1.85 | $0.18 | ||
| Q2 24 | — | $-0.33 | ||
| Q1 24 | — | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $159.3M | $119.0M |
| Total DebtLower is stronger | — | $69.5M |
| Stockholders' EquityBook value | $155.3M | $409.6M |
| Total Assets | $195.8M | $3.7B |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $159.3M | $119.0M | ||
| Q3 25 | $168.5M | $121.6M | ||
| Q2 25 | $177.4M | $134.4M | ||
| Q1 25 | $182.7M | $148.4M | ||
| Q4 24 | — | $120.4M | ||
| Q3 24 | $14.1M | $149.0M | ||
| Q2 24 | — | $109.7M | ||
| Q1 24 | — | $61.0M |
| Q4 25 | — | $69.5M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $69.9M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $155.3M | $409.6M | ||
| Q3 25 | $164.1M | $397.6M | ||
| Q2 25 | $172.2M | $380.0M | ||
| Q1 25 | $180.9M | $372.2M | ||
| Q4 24 | — | $362.7M | ||
| Q3 24 | $-136.0M | $363.5M | ||
| Q2 24 | — | $350.2M | ||
| Q1 24 | — | $211.7M |
| Q4 25 | $195.8M | $3.7B | ||
| Q3 25 | $199.5M | $3.6B | ||
| Q2 25 | $207.7M | $3.6B | ||
| Q1 25 | $213.5M | $3.6B | ||
| Q4 24 | — | $3.5B | ||
| Q3 24 | $47.1M | $3.5B | ||
| Q2 24 | — | $3.5B | ||
| Q1 24 | — | $2.4B |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.19× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-10.8M | $46.1M |
| Free Cash FlowOCF − Capex | $-11.0M | $43.6M |
| FCF MarginFCF / Revenue | -44.2% | 113.9% |
| Capex IntensityCapex / Revenue | 0.7% | 6.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-41.6M | $77.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-10.8M | $46.1M | ||
| Q3 25 | $-11.1M | $13.2M | ||
| Q2 25 | $-7.5M | $11.5M | ||
| Q1 25 | $-11.4M | $11.1M | ||
| Q4 24 | — | $22.2M | ||
| Q3 24 | — | $7.8M | ||
| Q2 24 | — | $5.2M | ||
| Q1 24 | — | $4.0M |
| Q4 25 | $-11.0M | $43.6M | ||
| Q3 25 | $-11.5M | $12.8M | ||
| Q2 25 | $-7.6M | $10.6M | ||
| Q1 25 | $-11.6M | $10.8M | ||
| Q4 24 | — | $17.2M | ||
| Q3 24 | — | $5.2M | ||
| Q2 24 | — | $4.8M | ||
| Q1 24 | — | $3.6M |
| Q4 25 | -44.2% | 113.9% | ||
| Q3 25 | -50.8% | 33.7% | ||
| Q2 25 | -35.9% | 29.6% | ||
| Q1 25 | -56.4% | 30.9% | ||
| Q4 24 | — | 50.0% | ||
| Q3 24 | — | 16.7% | ||
| Q2 24 | — | 15.7% | ||
| Q1 24 | — | 17.3% |
| Q4 25 | 0.7% | 6.6% | ||
| Q3 25 | 1.6% | 1.1% | ||
| Q2 25 | 0.3% | 2.7% | ||
| Q1 25 | 0.7% | 0.9% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 8.1% | ||
| Q2 24 | — | 1.4% | ||
| Q1 24 | — | 2.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.21× | ||
| Q2 25 | — | 1.47× | ||
| Q1 25 | — | 1.33× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.29× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
CWBC
Segment breakdown not available.